1-2 of 2
Lester Lledo, RN,MSN,CNP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pilot Study of Non-Viral, RNA-Redirected Autologous Anti-CD19 Chimeric Antigen Receptor Modified T-Cells in Patients with Refractory/Relapsed Hodgkin Lymphoma (HL)

Jakub Svoboda, MD, Susan R. Rheingold, MD, Saar I Gill, MD PhD, Stephan A Grupp, MD PhD, Simon F Lacey, PhD BS, J. Joseph Melenhorst, PhD, Irina Kulikovskaya, Brandon Loudon, Naseem Kerr, MPH, Katherine T Marcucci, PhD, Kim-Marie Shea, RN, Aliza Schmidt, MS, Lester Lledo, RN,MSN,CNP, Amy Marshall, Anthony R. Mato, MD, Sunita Dwivedy Nasta, MD, Daniel J. Landsburg, MD, Matthew R. Youngman, BS, Bruce L Levine, PhD, David L Porter, MD, Carl H June, MD, Stephen J. Schuster, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 653.
https://doi.org/10.1182/blood.V130.Suppl_1.653.653
Published: 2017
Journal Articles

Randomized, Phase II Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) in Patients with Relapsed, Refractory CLL

David L. Porter, MD, Noelle V. Frey, MDMS, J. Joseph Melenhorst, PhD, Wei-Ting Hwang, PhD, Simon F. Lacey, PhD BSc, Pamela Shaw, PhD, Anne Chew, PhD, Stephan A. Grupp, MD PhD, James Capobianchi, Joan Gilmore, Michael Kalos, PhD, Manuel Litchman, MD, Lester Lledo, RN,MSN,CNP, Alison Wakoff Loren, MDMS, Yolanda Mahnke, PhD, Katherine T. Marcucci, PhD, Holly McConville, RN, Angela Shen, MD, Patricia A. Wood, MD PhD, Zhaohui Zheng, Bruce L. Levine, PhD, Carl H. June, MD
Journal: Blood
Blood (2014) 124 (21): 1982.
https://doi.org/10.1182/blood.V124.21.1982.1982
Published: 2014